![]() |
市場調查報告書
商品編碼
1326476
傷口治療市場 - 2018-2028F 全球行業規模、佔有率、趨勢、機會和預測,按治療、按傷口類型、按應用、按最終用戶、按地區和競爭細分Wound Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Therapy, By Wound Type, By Application, By End User, By Region and Competition |
由於人們對傷口護理重要性的認知不斷增強以及傷口治療技術的進步,全球傷口治療市場預計在預測期內將以驚人的速度成長。多年來,由於慢性傷口發病率的增加以及新型創新傷口護理產品的開發,全球傷口治療市場出現了顯著成長。例如,幹細胞在傷口癒合中的應用是一個深入研究的領域,許多公司都在開發基於幹細胞的傷口護理產品。傷口護理技術的其他進步包括開發 3D 列印傷口敷料、可以監測傷口癒合的智慧敷料以及使用生物粘合劑的傷口閉合裝置。
慢性傷口是全球傷口治療市場的主要驅動力,佔整個市場的很大一部分。據美國疾病控制與預防中心 (CDC) 統計,美國約有 650 萬人患有慢性傷口,每年治療這些傷口的費用估計在 281 億美元至 317 億美元之間。傷口處理的總成本包括用品和敷料、護理時間和住院費用。一次又一次更換傷口敷料增加了傷口護理的總體成本,從而需要開發更先進的傷口治療方案,從而支持全球傷口治療市場的成長。
使用傳統方法進行傷口治療的高昂成本導致了新的和創新療法的開發,例如基於細胞的治療或皮膚替代品或使用由生物材料製成的傷口敷料等。
細胞是傷口治療不可或缺的一部分,它們的使用徹底改變了我們傷口癒合的方式。傷口是皮膚或粘膜破裂的開放性損傷,可由多種因素引起,如外傷、手術或慢性疾病。身體癒合傷口的能力取決於多種因素,例如傷口的範圍和位置、患者的健康狀況以及是否存在任何潛在的醫療狀況。細胞通過替換受損組織並促進新組織的生長,在傷口癒合過程中發揮著至關重要的作用。它們可以多種形式使用,包括基於細胞的療法、幹細胞和皮膚替代品,以增強癒合過程。基於細胞的療法涉及使用活細胞來促進癒合並改善受損組織的功能。這些療法通常用於慢性傷口,即使經過常規傷口護理也無法癒合。不同類型的細胞,包括成纖維細胞、角質形成細胞和內皮細胞,可用於促進傷口癒合。成纖維細胞是產生膠原蛋白的細胞,膠原蛋白是一種賦予組織強度和結構的蛋白質。角質形成細胞是產生角蛋白的細胞,角蛋白是皮膚的重要組成部分。內皮細胞是排列在血管上的細胞,在傷口床新血管的形成中發揮著至關重要的作用。
細胞在傷口治療中的使用有可能徹底改變整個全球傷口治療市場。與傳統傷口護理方法相比,這些療法具有多種優勢,並且有可能顯著改善患者的治療效果。隨著再生醫學領域的不斷發展,細胞在傷口治療中的使用可能會變得越來越普遍,為慢性傷口患者帶來新的希望,並為未來幾年全球傷口治療市場的成長創造新的前景。
除了新興的傷口治療方法外,還有幾種替代的傷口治療方法正在使用,例如加壓療法、傷口負壓療法和高壓氧療法。反過來,這些療法預計將為未來幾年替代傷口治療療法市場的成長開闢新的前景。壓迫療法用於治療容易流血或有形成血栓風險的傷口。該方法涉及使用壓縮繃帶或長襪對傷口施加壓力。壓迫療法最適合四肢傷口,例如靜脈潰瘍和深靜脈血栓形成。負壓傷口治療是一種更先進的傷口治療形式,用於大的慢性傷口。這種方法涉及對傷口施加真空,通過去除多餘的液體和增加血流量來促進癒合。負壓傷口治療最適合未癒合或有感染風險的傷口。高壓氧療法是一種特殊的傷口治療方式,用於治療因血流不暢而無法癒合的傷口。這種方法涉及將傷口暴露在高水平的氧氣中,通過增加血流量和促進新組織的生長來促進癒合。高壓氧療法最適合大且慢性的傷口。
根據給定的市場數據,TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項:
Global Wound Treatment Market is expected to grow at an impressive rate during the forecast period on account of the increasing awareness of the importance of wound care and advances in wound treatment technologies. Over the years, the global wound treatment market has witnessed significant growth on account of the increasing incidences of chronic wounds and the development of new and innovative wound care products. For example, the use of stem cells in wound healing is an area of intense research, with many companies developing stem cell-based wound care products. Other advances in wound care technology include the development of 3D-printed wound dressings, smart dressings that can monitor wound healing, and wound closure devices that use bioadhesives.
The wound treatment market is also being driven by the increasing use of wound care products in surgical procedures. Advances in wound care technology have made it possible to use wound care products to improve outcomes in surgical procedures, leading to an increase in the use of these products in the operating room.
Chronic wounds are a major driver of the global wound treatment market, accounting for a significant portion of the total market. According to the Centers for Disease Control and Prevention (CDC), approximately 6.5 million people in the United States suffer from chronic wounds, and the annual cost of treating these wounds is estimated to be between USD 28.1 billion and USD 31.7 billion. The overall cost of wound management includes supplies and dressings, nursing time, and hospitalization. Changing the wound dressings again and again adds up to the overall cost of wound care, thereby creating a need for the development of more advanced wound treatment options, hence supporting the growth of global wound treatment market.
The high cost of wound treatment using traditional methods has led to the development of new and innovative therapies, such as cell-based treatments or skin substitutes or using wound dressings made up of biomaterials, among others.
Cells are an integral part of wound treatment, and their use has revolutionized the way we approach wound healing. Wounds are open injury that breaks the skin or mucous membranes and can be caused by various factors such as trauma, surgery, or chronic diseases. The ability of the body to heal wounds is dependent on various factors, such as the extent and location of the wound, the patient's health status, and the presence of any underlying medical conditions. Cells play a crucial role in the wound-healing process by replacing damaged tissue and promoting the growth of new tissue. They can be used in a variety of forms, including cell-based therapies, stem cells, and skin substitutes, to enhance the healing process. Cell-based therapies involve using living cells to promote healing and improve the function of the damaged tissue. These therapies are often used in chronic wounds, which fail to heal even after conventional wound care. Different types of cells, including fibroblasts, keratinocytes, and endothelial cells, can be used to promote wound healing. Fibroblasts are cells that produce collagen, a protein that gives strength and structure to tissues. Keratinocytes are cells that produce keratin, a protein that is an essential component of skin. Endothelial cells are cells that line the blood vessels and play a vital role in the formation of new blood vessels in the wound bed.
The use of cells in wound treatment has the potential to revolutionize the overall global wound treatment market. These therapies offer several advantages over traditional wound care methods and have the potential to significantly improve patient outcomes. As the field of regenerative medicine continues to evolve, the use of cells in wound treatment is likely to become increasingly common, offering new hope for patients suffering from chronic wounds and creating new prospects for the growth of global wound treatment market in the coming years.
Apart from the emerging wound treatments, there are several alternative wound treatment therapies, such as compression therapy, negative wound pressure therapy, and hyperbaric oxygen therapy, which are being used. These therapies are, in turn, expected to open new prospects for the growth of the alternative wound treatment therapies market in the coming years. Compression therapy is used to treat wounds that have a tendency to bleed or are at risk of developing blood clots. This method involves applying pressure to the wound using compression bandages or stockings. Compression therapy is most appropriate for wounds that are on the limbs, such as venous ulcers and deep vein thrombosis. Negative pressure wound therapy is a more advanced form of wound treatment that is used for large, chronic wounds. This method involves applying a vacuum to the wound, which promotes healing by removing excess fluid and increasing blood flow. Negative pressure wound therapy is most appropriate for wounds that are not healing or are at risk of becoming infected. Hyperbaric oxygen therapy is a specialized form of wound treatment that is used for wounds that are not healing due to poor blood flow. This method involves exposing the wound to high levels of oxygen, which promotes healing by increasing blood flow and promoting the growth of new tissue. Hyperbaric oxygen therapy is most appropriate for wounds that are large and chronic.
Global Wound Treatment Market can be segmented by therapy, wound type, application, end-user, and by region. Based on therapy, global wound treatment market can be categorized into instrumental-based therapy, platelet therapy, cell therapy, and wound dressings. By wound type, the global wound treatment market can be segmented into subcutaneous abdominal wounds, traumatic & infected wounds, bilateral reduction mammaplasty, and others. In terms of application, global wound treatment market can be grouped into burns, ulcers, cuts & lacerations, and others. By end user, the global wound treatment market can be grouped into hospitals & clinics, ambulatory surgery centers, homecare, and others. Regionally, global wound treatment market can be categorized into North America, Europe, Asia Pacific, Middle East & Africa, and South America. The United States dominated the North America market in 2022 and the overall global wound treatment market over other countries on account of the rising patient pool in the country coupled with an increasing geriatric population base which is at a higher risk of developing wounds. This, in turn, is expected to increase the demand for different wound care methods and products, thereby driving the growth of global wound treatment market. According to the Administration for Community Living, which includes the Administration on Aging, which is an operating division of the U.S. Department of Health and Human Services, the population aged 65 and above reached 54.1 million in 2019 from 39.6 million in 2009 and is projected to reach 94.7 million in 2060. By 2040, there will be about 80.8 million older persons, more than twice as many as in 2000. The growing geriatric population will support the growth of global wound treatment market in the coming years. However, the Asia Pacific region is expected to register the highest growth during the forecast period on account of the increasing prevalence of various chronic diseases in the region, especially in the highly populous countries of China and India.
3M Company, ConvaTec Group PLC, Molnlycke Health Care AB, Smith & Nephew plc, Organogenesis, Inc, Coloplast A/S, MiMedx Group, Inc., Integra LifeSciences Corporation, Johnson & Johnson, Medtronic Plc., among others are some of the leading players operating in the global wound treatment market.
In this report, Global Wound Treatment Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Wound Treatment Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: